TT

Kathryne E Marks1, Ifeoluwakiisi Adejoorin2, John Sowerby1

  • 1Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

STAR protocols
|January 5, 2025
PubMed
概括

这项研究详细介绍了测量人类T细胞细胞毒性的新协议. 该方法评估T细胞受体 (TCR) 触发和目标细胞杀死使用流细胞计,适用于小患者样本.